Use the Back button in your browser to see the other results of your search or to select another record.
Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial |
Moug SJ, Barry SJE, Maguire S, Johns N, Dolan D, Steele RJC, Buchan C, Mackay G, Anderson AS, Mutrie N |
Techniques in Coloproctology 2020 Sep;24(9):959-964 |
clinical trial |
6/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|